These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24993094)

  • 1. Prognostic effect of p53 expression in patients with completely resected colorectal cancer.
    Liu BW; Liu Y; Liu JR; Feng ZX; Liu T
    Tumour Biol; 2014 Oct; 35(10):9893-6. PubMed ID: 24993094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoexpression of TS, p53, COX2, EGFR, MSH6 and MLH1 biomarkers and its correlation with degree of differentiation, tumor staging and prognostic factors in colorectal adenocarcinoma: a retrospective longitudinal study.
    Batista WR; Santos G; Vital FMR; Matos D
    Sao Paulo Med J; 2019 May; 137(1):33-38. PubMed ID: 31116268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
    Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
    Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of programmed death ligand 1, p53, and Ki-67 in patients with advanced-stage colorectal cancer.
    Wang L; Liu Z; Fisher KW; Ren F; Lv J; Davidson DD; Baldridge LA; Du X; Cheng L
    Hum Pathol; 2018 Jan; 71():20-29. PubMed ID: 28782638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of p53 expression and p21 loss has an independent prognostic impact on sporadic colorectal cancer.
    Noske A; Lipka S; Budczies J; Müller K; Loddenkemper C; Buhr HJ; Kruschewski M
    Oncol Rep; 2009 Jul; 22(1):3-9. PubMed ID: 19513497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of p53 for colorectal cancer after surgical resection of pulmonary metastases.
    Li C; Xu Q; Chen L; Luo C; Chen Y; Ying J
    World J Surg Oncol; 2016 Dec; 14(1):308. PubMed ID: 28003030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer.
    Nasif WA; Lotfy M; El-Sayed IH; El-Kenawy Ael-M; El-Shahat M; El-Hak NG
    Med Oncol; 2006; 23(2):237-44. PubMed ID: 16720924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and Prognostic Value of Oestrogen Receptor Beta in Colorectal Cancer.
    Pérez-Ruiz E; Rueda A; Pérez L; Rivas-Ruiz F; Torres E; de Luque V; Álvarez M; Sevilla I; Redondo M; Padilla-Ruiz M; Alba E; Alonso L
    Pathol Oncol Res; 2018 Oct; 24(4):871-879. PubMed ID: 28889324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear p53 protein expression in resected hepatic metastases from colorectal cancer: an independent prognostic factor of survival.
    Nitti D; Belluco C; Montesco MC; Bertorelle R; Da Pian PP; Fassina A; Ninfo V; Chieco-Bianchi L; Lise M
    Eur J Cancer; 1998 May; 34(6):851-5. PubMed ID: 9797697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.
    Yao W; Qin X; Qi B; Lu J; Guo L; Liu F; Liu S; Zhao B
    Int J Clin Exp Pathol; 2014; 7(10):7158-63. PubMed ID: 25400812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma.
    Diez M; Pollan M; Müguerza JM; Gaspar MJ; Duce AM; Alvarez MJ; Ratia T; Herñandez P; Ruiz A; Granell J
    Cancer; 2000 Jan; 88(1):35-41. PubMed ID: 10618603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
    Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
    Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.
    Wangefjord S; Brändstedt J; Lindquist KE; Nodin B; Jirström K; Eberhard J
    Diagn Pathol; 2013 Jan; 8():10. PubMed ID: 23337059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancer.
    Arriaga JM; Bravo IA; Bruno L; Morales Bayo S; Hannois A; Sanchez Loria F; Pairola F; Huertas E; Roberti MP; Rocca YS; Aris M; Barrio MM; Baffa Trasci S; Levy EM; Mordoh J; Bianchini M
    Hum Pathol; 2012 Oct; 43(10):1695-703. PubMed ID: 22516242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chaperone protein L-isoaspartate (D-aspartyl) O-methyltransferase as a novel predictor of poor prognosis in lung adenocarcinoma.
    Saito H; Yamashita M; Ogasawara M; Yamada N; Niisato M; Tomoyasu M; Deguchi H; Tanita T; Ishida K; Sugai T; Yamauchi K
    Hum Pathol; 2016 Apr; 50():1-10. PubMed ID: 26997432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
    Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
    Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
    Xi HQ; Zhao P
    J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High RAD54B expression: an independent predictor of postoperative distant recurrence in colorectal cancer patients.
    Nagai Y; Yamamoto Y; Yasuhara T; Hata K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Yamanaka T; Miyagawa K; Watanabe T
    Oncotarget; 2015 Aug; 6(25):21064-73. PubMed ID: 26046797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRIM-19 expression is a potent prognostic marker in colorectal cancer.
    Hao M; Shu Z; Sun H; Sun R; Wang Y; Liu T; Ji D; Cong X
    Hum Pathol; 2015 Dec; 46(12):1815-20. PubMed ID: 26363526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p16INK4a, alone or combined with p53, is predictive of better prognosis in colorectal adenocarcinoma in Tunisian patients.
    Miladi-Abdennadher I; Abdelmaksoud-Damak R; Ayadi L; Khabir A; Amouri A; Frikha F; Ellouz S; Frikha M; Sellami-Boudawara T; Mokdad-Gargouri R
    Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):562-8. PubMed ID: 22095233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.